P
arapneumonic effusion is present in approximately 40% of patients with community-acquired pneumonia (CAP). 1 In addition to microbiological tests, the biochemical examination of pleural fluid is essential to guide management of patients. In fact, it has been suggested that pleural fluid should be obtained from any patients with CAP in whom a sufficient amount of pleural effusion is detected. 2 Certainly, thoracentesis constitutes an unquestionable recommendation, included in all recently published guidelines. [3] [4] [5] However, pleural space has a close relation to lung parenchyma; consequently, pleural fluid appears to be a very attractive target for etiologic studies of pneumonia. Unfortunately, Gram stain and culture of pleural fluid are relatively insensitive; and antigen detection methods, which showed initial promising results, have not been subsequently validated. 6 Polymerase chain reaction (PCR) is a new diagnostic method that offers many potential advantages: results are positive early in the course of infection, it is unaffected by the prior administration of antibiotics, and it is not dependent on a host response. In addition, the sample can be stored and tested or retested months or years later. 7 This test has been efficaciously employed in experimental or clinical studies to detect Streptococcus pneumoniae DNA in a variety of body fluids. 8 -11 We demonstrated that this test, applied to blood samples, is useful to diagnose bacteremic and nonbacteremic patients with pneumococcal pneumonia. 12 However, the usefulness of PCR in pleural fluid has not been extensively evaluated. The purpose of the present study was to analyze, in a group of unselected control subjects and patients with CAP and pleural effusion, the utility of PCR in pleural fluid to diagnose pneumococcal pneumonia.
Materials and Methods

Study Subjects
Over a 3-year period (from January 1998 until the end of December 2000), 261 adult patients with a clinical and radiologic picture suggestive of CAP were admitted at our institution; a sufficient amount of pleural fluid to be aspirated was radiologically identified in 51 patients (19%), and they were enrolled into the present study. In addition, 51 unselected patients with pleural effusion due to other conditions were also included and used as control subjects. Informed consent was obtained from patients, and the study was approved by the ethical and the scientific committees of our institution.
Study Design
Collection and Study of Samples: For all patients, a sample of pleural fluid, obtained by thoracentesis, was bacteriologically (Gram stain, and aerobic and anaerobic cultures) and biochemically analyzed; a fraction of the remaining sample was stored at Ϫ 70°for later PCR determination.
For patients with CAP, samples of blood and sputum (when available) were collected for microbiological testing by standard culture techniques, paired serum samples for acute and convalescent phases were also obtained for serologic studies, and one additional blood sample was also stored for PCR detection. Finally, urine samples were collected and processed for Legionella pneumophila (since October 1999) and for S pneumoniae (since March 2000) antigen detections.
Definition of Etiologic Diagnostic Criteria for Patients With CAP:
A diagnosis of pneumococcal pneumonia was established when S pneumoniae was isolated from blood, pleural fluid, or sputum; a specific sequence of the pneumolysin gene was detected in blood or the antigen was detected in urine. Pneumonia was caused by other microorganisms when a fourfold or greater rise in serologic titers was observed; a respiratory pathogen was isolated from blood, pleural fluid, or sputum; or antigen of L pneumophila was detected in urine. The remaining patients were classified as patients with pneumonia of unknown etiology.
PCR Technique: Two hundred-microliters of samples (pleural fluid and whole blood) were processed by using the QIAamp Blood Kit (QIAgen; Hilden, Germany) for extraction of S pneumoniae DNA. For DNA amplification, we employed the nested-PCR method. The selection of two primer pairs was based on the published pneumolysin gene sequence. 13 The technical characteristics of the method for DNA amplification have been described. 12 The amplified product was analyzed by 2% agarose gel electrophoresis and ethidium bromide staining, and examined by ultraviolet transillumination. For confirmation of positive results, a nonradioactive DNA hybridization technique was performed using a biotin-labeled probe. The sensitivity limit of the assay was experimentally evaluated by means of serial dilutions of whole S pneumoniae in blood and pleural fluid samples; 10 cfu/50 L was the minimal amount of microorganisms in both samples needed to provide positive results.
Statistical Analysis
The final diagnosis of cases, according to criteria previously defined, was used as the standard for determining the diagnostic usefulness of the PCR method in terms of sensitivity, specificity, and predictive values. In consequence, patients with pneumonia of unknown etiology and patients with pneumonia caused by microorganisms other than S pneumoniae were considered as cases of nonpneumococcal pneumonia. Control subjects were not included in the statistical analysis.
Results
Patient Characteristics
One hundred two samples of pleural fluid (51 samples from patients with CAP and 51 samples from control subjects) were included in the study. For patients with CAP, mean age was 53 years (range, 20 to 87 years); 33 patients (65%) were men, and 35 patients (69%) had coexisting diseases. Before hospital admission, six patients had received antimicrobial therapy. The amount of pleural effusion, measured as the area of the hemithorax occupied by the collection in basis to the chest radiograph, could be considered as mild (Ͻ 33%) in 25 patients, moderate (between 33% and 66%) in 22 patients, and massive (Ͼ 66%) in 4 patients. During follow-up, two patients (4%) required admission to the ICU and five patients (10%) died.
For control subjects, mean age was 60 years (range, 18 to 86 years) and 35 of them (69%) were men. Predominant underlying diseases were neoplasm (15 patients), congestive heart failure (13 patients), and tuberculosis (9 patients). For both groups, relevant adverse events attributable to thoracentesis were not observed.
Etiologic Studies
Pleural fluid culture results were positive in 11 patients (22%) with CAP and pleural effusion, and negative in all control subjects, yielding S pneumoniae in 2 patients, Staphylococcus aureus in 2 A diagnosis of pneumococcal pneumonia was made in nine patients, of whom two patients had positive pleural fluid culture result. (A detailed description of microbiological results from these patients with pneumococcal pneumonia is shown in Table 1 .) A diagnosis of nonpneumococcal pneumonia was established in 18 cases, with the following etiologies: anaerobic and microaerophilic streptococci (n ϭ 12); S aureus (n ϭ 3); S viridans (n ϭ 3); Streptococcus milleri (n ϭ 1); Enterobacter aerogenes (n ϭ 1); Pseudomonas aeruginosa (n ϭ 1); Escherichia coli (n ϭ 1); Enterococcus faecalis (n ϭ 1); Staphylococcus epidermidis (n ϭ 1); and M pneumoniae (n ϭ 1). For the remaining 24 patients, the etiology was not found.
Results of PCR in Pleural Fluid Specimens for S pneumoniae DNA Detection
PCR findings in pleural fluid were positive in seven of nine patients with pneumococcal pneumonia; findings were positive in both patients with positive pleural fluid culture findings for S pneumoniae, and in five of seven patients with negative culture findings (Table 1 ). In consequence, the sensitivity was 78%.
PCR findings in pleural fluid were also positive in 3 of 24 patients (12%) with pneumonia of unknown etiology, and negative in all patients with pneumonia caused by nonpneumococcal species. Then, we can calculate a specificity of 93%, a positive predictive value of 70%, and a negative predictive value of 95%. Finally, test results were positive in 2 of 51 patients (4%) with pleural effusion related to other diseases; one patient had a pleural effusion secondary to thoracic traumatism, the other patient had Dressler syndrome, and both patients had no clinical manifestations of active infection.
Discussion
The results of the present study showed that PCR on pleural fluid samples can be a valuable test to diagnose pneumococcal pneumonia. The sensitivity and the specificity of the method were 78% and 93%, respectively, in patients with pneumonia, attending to results provided by alternative techniques. In comparison, the sensitivity of pleural fluid culture was only 22%. In addition, the PCR results were positive in 12% of patients with pneumonia of unknown etiology; although these cases were considered as false-positive results, they might certainly represent patients with pneumococcal pneumonia undetected by conventional methods. Unfortunately, a few unquestionably false-positive results were observed in the study of patients without pneumonia.
Prospective studies evaluating the etiology of CAP in adults have failed to identify the cause in 40 to 60% of patients. Blood cultures are very specific, but they have a low sensitivity, and the significance of Gram stain and culture of sputum is uncertain. 2 In this context, pleural fluid, when present, can be considered as an attractive target to perform etiologic studies for several reasons. First, a significant amount of parapneumonic effusion is detected by chest radiography in approximately 40% of patients with CAP. 1 Second, in addition to the microbiology, biochemical examination is very useful for guiding therapeutic decisions; therefore, when a clinically important effusion is present, the pleural aspiration should be done routinely. And finally, the technique is not uncomfortable for patients, is associated with a low risk of complications, and always provides a valuable and specific sample, if we exclude a potential contamination by the habitual skin flora. However, the bacteriologic study of pleural fluid, based on Gram stain and cultures, is limited by the lack of sensitivity, particularly when criteria for empyema or complicated parapneumonic effusion are absent. 14 Therefore, investigations with the use of new and more sensitive tests are needed.
To date, the value of these novel diagnostic tests on pleural fluid has not been sufficiently evaluated. The usefulness of pneumococcal antigen detection in pleural fluid, by latex particle agglutination, was studied by Boersma et al 6 in 1993; they found, in comparison with culture, a higher sensitivity and a specificity of 92%. Unfortunately, further articles on this subject have not been published. Similarly, studies with PCR to detect S pneumoniae DNA have been assayed on a diversity of samples such as middle ear fluid, 8 cerebrospinal fluid, 9 and serum or blood. 10 We also analyzed the value of the method in samples obtained by transthoracic needle aspiration 15 and in whole-blood samples from bacteremic and nonbacteremic patients with pneumonia, 12 with promising results. However, experiences with PCR on pleural fluid samples are very scarce, and are addressed to detect other pathogens such as M pneumoniae and particularly Mycobacterium tuberculosis. 16 -18 In fact, studies of pneumococcal pneumonia have not been reported.
A positive Gram stain or pleural fluid culture finding suggests the presence of a complicated parapneumonic effusion; it rarely resolves with antibiotics alone and has a high likelihood of requiring pleural drainage. 19 We could speculate about the real significance of a positive PCR test result without isolation of the microorganism. Certainly, the threshold number of pneumococci required for PCR to be detectable is considerably lower than culture. Studies have shown that approximately 10 6 microorganisms per milliliter are required before a culture yields colonies on an agar plate 20 ; for nested PCR, the presence of only 10 cfu/mL can be detected. 21 Thus, it is not surprising that patients with positive PCR findings in pleural fluid but negative culture results can be successfully managed with more conservative measures.
Although the specificity of the PCR in pleural fluid was high in patients with parapneumonic effusion, we found a 4% rate of positive results among control subjects, whose pleural effusions were caused by diseases other than CAP. The presence of some false-positive results has been previously reported by others, with a prevalence between 4% and 17%, 9, 21, 22 as could be the case of our control patients with positive results. We also described, in evaluating whole-blood samples, a similar frequency of falsepositive PCR results in control subjects. 12 This fact, attributable to asymptomatic pneumococcal nasopharyngeal carriage of patients or to contamination of sample or reactives in the laboratory during the processing period, constitutes an important handicap of the test. However, inhibitors can be present in clinical specimens, particularly in blood-containing samples, leading to some surprising false-negative PCR results. 12, 23 Therefore, in the future, technical refinements need to be included in order to eliminate these false results.
Conclusion
Our study constitutes a preliminary report showing the potential use of this test in pleural fluid. The high sensitivity observed supports the evaluation of the method in a larger group of patients with pneumonia caused by S pneumoniae.
